scholarly article | Q13442814 |
P50 | author | Clifford J. Woolf | Q5132981 |
Marco Sisignano | Q37372310 | ||
Ru-Rong Ji | Q42386007 | ||
Natasja de Bruin | Q59682589 | ||
Michael Parnham | Q66952188 | ||
P2093 | author name string | Mike Schmidt | |
Di Liu | |||
Holger Jordan | |||
Gerd Geisslinger | |||
Ruirui Lu | |||
Klaus Scholich | |||
Carlo Angioni | |||
Yannick Schreiber | |||
Jing Suo | |||
Chul-Kyu Park | |||
Dong-Dong Zhang | |||
Martine Hofmann | |||
Sascha Meyer Dos Santos | |||
Sebastian Zinn | |||
Stephan M G Schäfer | |||
Ajay S Yekkirala | |||
Maria Kuzikov | |||
Béla Zimmer | |||
Stephan W Hohman | |||
P2860 | cites work | Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and mice | Q21132412 |
Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents | Q21146964 | ||
Interventions for preventing neuropathy caused by cisplatin and related compounds | Q24236661 | ||
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases | Q24597172 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo | Q28238324 | ||
20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel | Q28261243 | ||
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors | Q28264127 | ||
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances | Q28344313 | ||
Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia | Q28582168 | ||
Neurogenic Inflammation – The Peripheral Nervous System’s Role in Host Defense and Immunopathology | Q28972495 | ||
Drug-induced prolongation of the QT interval | Q33151147 | ||
Prostaglandins and inflammation | Q34179727 | ||
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial | Q34336573 | ||
Antioxidants accelerate lung cancer progression in mice | Q34400895 | ||
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial | Q34403098 | ||
Action of epoxyeicosatrienoic acids on cellular function | Q34567484 | ||
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues | Q34663619 | ||
Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. | Q35452699 | ||
Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms | Q35675208 | ||
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NC | Q35847455 | ||
Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation | Q35897768 | ||
5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals | Q35987054 | ||
The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4 | Q36106866 | ||
Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation | Q36199024 | ||
Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). | Q36350876 | ||
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel | Q36862832 | ||
Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons | Q37094339 | ||
Chemotherapy-induced peripheral neuropathy: prevention and treatment | Q37911252 | ||
Cellular mechanisms and physiological consequences of redox-dependent signalling | Q38214052 | ||
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation | Q38736745 | ||
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. | Q40773486 | ||
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes | Q42284671 | ||
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation | Q42743261 | ||
CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro | Q43874398 | ||
Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion | Q44178415 | ||
A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain | Q44341121 | ||
Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain | Q45029206 | ||
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. | Q46054832 | ||
The neuropeptide calcitonin gene-related peptide (CGRP) stimulates T cell migration into collagen matrices | Q46635643 | ||
Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. | Q46883191 | ||
Slack channels expressed in sensory neurons control neuropathic pain in mice. | Q51015877 | ||
Breast cancer: weekly paclitaxel--still preferred first-line taxane for mBC. | Q53384579 | ||
The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. | Q53514776 | ||
Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. | Q54573883 | ||
TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism | Q59558854 | ||
P433 | issue | 44 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuropathic pain | Q2798704 |
P304 | page(s) | 12544-12549 | |
P577 | publication date | 2016-10-17 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain | |
P478 | volume | 113 |
Q100388930 | Antinociceptive modulation by the adhesion GPCR CIRL promotes mechanosensory signal discrimination |
Q58790284 | Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro |
Q55625734 | Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes. |
Q47868681 | Thermo-Sensitive TRP Channels: Novel Targets for Treating Chemotherapy-Induced Peripheral Pain |
Q58697842 | Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways |
Q64060383 | X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activation |
Q47570962 | Zinc Inhibits TRPV1 to Alleviate Chemotherapy-Induced Neuropathic Pain |
Search more.